Literature DB >> 17182253

Protective effects of mycosporine-like amino acids of Synechocystis sp. PCC 6803 and their partial characterization.

Lianwen Zhang1, Lianzhi Li, Qingyu Wu.   

Abstract

In this work, mycosporine-like amino acids (MAAs) of Synechocystis sp. PCC 6803 were characterized and were investigated on UV induction and protective ability. High performance liquid chromatographic (HPLC) studies revealed three major compounds in the MAAs. By UV absorption and mass spectra analysis, one of the compounds was tentatively identified as mycosporine-tau (M-tau). One novel compound similar to usujirene was tentatively named as dehydroxylusujirene, and the other novel compound was named as M-343 according to its absorption maximum. In vivo experiments indicated that M-tau was induced by both UV-A and UV-B, while dehydroxylusujirene and M-343 were only induced by UV-A, suggesting that different chromophores were involved in MAAs synthesis in Synechocystis sp. PCC 6803. It was also indicated that M-343 could be photochemically synthesized from some precursors. Under both UV and oxidation stresses, M-343 was more stable than dehydroxylusujirene and M-tau. Considering the reaction with H2O2, M-tau and dehydroxylusujirene might be potential antioxidants in reaction with physiological reactive oxygen species in vivo. In protection experiments, the MAAs exhibited efficient protective ability towards UV-B and H2O2 stresses, with maximal protection rates of 30% and 21.5%, respectively. These results indicate that the MAAs in Synechocystis sp. PCC 6803 act as both UV-screen and antioxidant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17182253     DOI: 10.1016/j.jphotobiol.2006.10.006

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  9 in total

1.  The sll1951 gene encodes the surface layer protein of Synechocystis sp. strain PCC 6803.

Authors:  Christoph Trautner; Wim F J Vermaas
Journal:  J Bacteriol       Date:  2013-09-27       Impact factor: 3.490

Review 2.  The chemical ecology of cyanobacteria.

Authors:  Pedro N Leão; Niclas Engene; Agostinho Antunes; William H Gerwick; Vitor Vasconcelos
Journal:  Nat Prod Rep       Date:  2012-01-12       Impact factor: 13.423

Review 3.  Mycosporine-like amino acids: relevant secondary metabolites. Chemical and ecological aspects.

Authors:  Jose I Carreto; Mario O Carignan
Journal:  Mar Drugs       Date:  2011-03-21       Impact factor: 5.118

Review 4.  Mycosporine-Like Amino Acids and Their Derivatives as Natural Antioxidants.

Authors:  Naoki Wada; Toshio Sakamoto; Seiichi Matsugo
Journal:  Antioxidants (Basel)       Date:  2015-09-07

Review 5.  Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer.

Authors:  Elena Talero; Sofía García-Mauriño; Javier Ávila-Román; Azahara Rodríguez-Luna; Antonio Alcaide; Virginia Motilva
Journal:  Mar Drugs       Date:  2015-09-30       Impact factor: 5.118

Review 6.  The Potential of Cryptophyte Algae in Biomedical and Pharmaceutical Applications.

Authors:  Maryam Abidizadegan; Elina Peltomaa; Jaanika Blomster
Journal:  Front Pharmacol       Date:  2021-02-02       Impact factor: 5.810

Review 7.  Microalgae as a Source of Mycosporine-like Amino Acids (MAAs); Advances and Future Prospects.

Authors:  Subhisha Raj; Anusree M Kuniyil; Arathi Sreenikethanam; Poornachandar Gugulothu; Rajesh Banu Jeyakumar; Amit K Bajhaiya
Journal:  Int J Environ Res Public Health       Date:  2021-11-25       Impact factor: 3.390

8.  Glycosylated porphyra-334 and palythine-threonine from the terrestrial cyanobacterium Nostoc commune.

Authors:  Ehsan Nazifi; Naoki Wada; Minami Yamaba; Tomoya Asano; Takumi Nishiuchi; Seiichi Matsugo; Toshio Sakamoto
Journal:  Mar Drugs       Date:  2013-08-26       Impact factor: 5.118

Review 9.  The Role of the Cyanobacterial Type IV Pilus Machinery in Finding and Maintaining a Favourable Environment.

Authors:  Fabian D Conradi; Conrad W Mullineaux; Annegret Wilde
Journal:  Life (Basel)       Date:  2020-10-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.